Stock A128940 HANMI PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hanmi Pharm. Co., Ltd.

Equities

A128940

KR7128940004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
310,500 KRW +0.16% Intraday chart for Hanmi Pharm. Co., Ltd. +0.65% -11.91%
Mar. 19 Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 31 Aptose Biosciences Inc. announced that it has received $4 million in funding from Hanmi Pharm. Co., Ltd. CI

Evolution of the average Target Price on Hanmi Pharm. Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

0b41e156b4e983aa2398f9e8fac8.24qk-LChxgcWhebhFccnjmTVSH4i3Dkpg9jC5KeGPSg.n7vLwYnKjFBhvKSFdJJU5RDjeR0a6FtBz5Wy0Z_LRFnt5POJ-fGeVVCxtw~b9fbeaa149e295ce0d3d42f05ac871ac

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
310,500 KRW
Average target price
408,486 KRW
Spread / Average Target
+31.56%
High Price Target
440,000 KRW
Spread / Highest target
+41.71%
Low Price Target
327,759 KRW
Spread / Lowest Target
+5.56%

Consensus detail

Consensus revision (last 18 months)

Ratings for Hanmi Pharm. Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A128940 Stock
  4. Consensus Hanmi Pharm. Co., Ltd.